Largo Inc. is optimizing its production to focus on higher-margin products like high-purity vanadium and copper-platinum group metal (PGM) concentrates, which currently yield over 90% operating profit margins. The company has shipped its first high-purity vanadium to the U.S. Defense Logistics Agency and plans to potentially double copper-PGM concentrate production by 2027. This strategy aims to improve cash flow by increasing the share of premium products despite a slight reduction in total vanadium output. Additionally, Largo has made progress in restructuring nearly half of its $82 million commercial bank debt, enhancing financial stability.
Largo Inc.'s strategic focus on higher-margin products like high-purity vanadium and copper-PGM concentrates is presented here with Pluang's Basic Materials sector data for context. For readers following this sector, as of Sep 23, 2026 19:11 WIB, 9 of 38 priced US Basic Materials stocks rose while 29 fell. Southern Copper Corp (SCCO) traded at USD 201.00 with 74% sell orders, Wheaton Precious Metals Corp (WPM) at USD 150.06 with 67% buy orders, and Freeport-McMoRan Inc (FCX) at USD 72.56 with 92% sell orders, showing contrasting investor sentiment and typical hold times ranging from 59 to 69 days on Pluang.
A Snap insider has sold 20,000 shares as the company's stock has declined by 27% over the last year. This insider sale may signal concerns about the stock's near-term prospects or a personal decision to liquidate holdings. Investors should watch for ...
Dogecoin (DOGE) has gained over $171 million in market cap recently, driven by a broader altcoin rally. Three AI platforms—Grok, Gemini, and ChatGPT—forecast an average price increase to $0.1082 by October 1, 2026, suggesting an 8.82% rise from curre...
Analyst Ali Martinez identifies a bullish reversal for the altcoin SUI following an 83% drop from previous highs. Three key weekly indicators—the Tom DeMark Sequential, SuperTrend, and Parabolic SAR—have flipped to buy signals, confirming a potential...
Micron's stock has risen 18.17% this week, closing at $1,096.16, with Wall Street analysts divided on price targets ranging from hold to $2,000 ahead of its September 30 earnings report. The company expects $50 billion in revenue and $31.00 non-GAAP ...
Bio-Techne shareholders have voted to approve the acquisition agreement with Merck KGaA, marking a key step toward completing the merger. The deal, which combines Bio-Techne's life science tools with Merck's global capabilities, aims to enhance suppo...
